Gynecologic procedures performed under moderate sedation, including hysteroscopy, dilation and curettage, endometrial ablation, oocyte retrieval, and minor vulvar or cervical interventions, have traditionally incorporated short-acting opioids to address procedural pain. However, opioid-related adverse effects—including respiratory depression, postoperative nausea and vomiting, delayed recovery, hyperalgesia, and the potential for persistent use—drives interest in opioid-sparing and opioid-free strategies. There are multiple options for effective analgesia for gynecologic procedures under moderate sedation and the resulting pelvic pain, including some alternatives to opioid analgesia.
Nonsteroidal anti-inflammatory drugs and acetaminophen form the cornerstone of many opioid-sparing protocols. Preprocedural administration of intravenous ketorolac or oral ibuprofen reduces prostaglandin-mediated uterine cramping and inflammatory pain, which are particularly relevant during endometrial manipulation. Acetaminophen, administered orally or intravenously, provides central analgesic effects and has demonstrated additive benefit when combined with NSAIDs. When given preemptively, these agents can reduce intraoperative analgesic requirements and improve early recovery profiles without increasing sedation-related risk.
Regional and local anesthetic techniques are valuable in some gynecologic procedures and may function as opioid-sparing alternatives for analgesia. Paracervical block with lidocaine remains a highly effective method for attenuating pain during cervical dilation and intrauterine instrumentation. When performed with appropriate technique and dosing, paracervical block significantly reduces procedural discomfort and may obviate the need for systemic opioids in select patients. Adjunctive intracervical or topical local anesthetics can further enhance analgesia. For vulvar and perineal procedures, targeted pudendal nerve block or local infiltration provides focused somatic pain control while preserving respiratory function and facilitating rapid discharge.
Ketamine, administered in subanesthetic doses, offers a useful adjunct in moderate sedation protocols. Low-dose ketamine, typically 0.1 to 0.3 mg/kg intravenously, provides analgesia through NMDA receptor antagonism without significant respiratory depression. Its dissociative properties can attenuate procedural discomfort while maintaining airway reflexes. When combined with propofol in carefully titrated regimens, ketamine may counteract propofol-induced hypotension and reduce total sedative requirements, though it carries its own side effects.
Dexmedetomidine offers another non-opioid alternative that provides both sedation and analgesia via central alpha-2 adrenergic agonism and can be beneficial for minor gynecologic procedures under sedation. It produces cooperative sedation with minimal respiratory depression and has been used successfully for hysteroscopic and minor operative procedures. Dexmedetomidine can reduce the need for supplemental analgesics, though bradycardia and hypotension require monitoring. Its relatively slower onset compared with propofol may necessitate anticipatory dosing or infusion-based strategies.
Gabapentinoids have been investigated as adjuncts in perioperative analgesia, though their role in short ambulatory gynecologic procedures remains selective. While preoperative gabapentin may reduce postoperative pain and opioid consumption, concerns regarding sedation and dizziness may limit routine use in moderate sedation settings where rapid recovery is desired.
Nonpharmacologic strategies should not be overlooked. Preprocedural counseling, anxiolysis, and expectation management can meaningfully influence pain perception. Techniques such as guided imagery or calming environmental modifications may complement pharmacologic measures. In selected office-based procedures, cervical priming agents may reduce the force required for dilation, thereby decreasing procedural pain.
Implementation of opioid-sparing strategies or opioid alternatives requires individualized assessment of patient comorbidities, the complexity of the gynecologic procedure, and anticipated level of analgesia needed. Multimodal combinations of NSAIDs, acetaminophen, regional anesthesia, and adjuncts such as ketamine or dexmedetomidine can provide effective analgesia while minimizing respiratory compromise and postoperative adverse effects. As enhanced recovery principles increasingly extend to ambulatory gynecology, careful integration of these alternatives supports improved patient outcomes, shorter recovery times, and reduced reliance on opioid analgesics in moderate sedation practice.
